Ardis Callie on Standardisation and Documentation of VTE Risk Assessments
Ardis Callie, Research Assistant, Intersection of Australian Healthcare Standards and Clinical Governance, shared on LinkedIn:
”Quality Statement 1: Standardised and documented VTE risk assessments using an agreed risk tool on admission for all patients including day cases, would be a low cost, good start to VTE prevention.
That way, chemoprophylaxis could be provided in appropriate cases.
Sadly, surgeons I know, in some private hospitals at least, assume all day cases are low risk, don’t conduct VTE risk assessments, and prioritise short term bleeding risk and ignore the consequences for the patient when they go home (despite the national VTE Prevention Clinical Care Standard 2020).
Queensland Health follows a stricter 2018 guideline so patients should be in good hands in those facilities.
Comments welcome from those in the know.”
Stay updated with Hemostasis Today.
-
Aug 11, 2026, 07:50When Access to Care Changes Everything – WFH
-
Aug 11, 2026, 07:41Kevin Land: How Cellular Therapy Is Changing Transfusion Medicine
-
Aug 11, 2026, 07:35Kuldeep Singh Bhadauria: Building the Future of Hemophilia Care in India
-
Aug 11, 2026, 07:28Archil Jaliashvili: When Every Minute Matters Time Becomes a Therapy
-
Aug 11, 2026, 07:05Mavis Agnes Kisakye: Building Sustainable Transition Pathways in Hemophilia Care
-
Aug 11, 2026, 06:48Rishdha Roshad: What Happens to the Brain During Cardiopulmonary Bypass?
-
Aug 11, 2026, 05:53Isaac Okello: Strengthening Sickle Cell Advocacy in Uganda
-
Aug 11, 2026, 05:38Rami Unterman: A Simple New Biomarker for Fibrotic ILDs
-
Aug 11, 2026, 04:10Haroun Gajraj: CLaCS vs Sclerotherapy – What Does the Evidence Show